Improving epilepsy seizure detection with advanced EEG technology
Epilepsy Seizure Detection with Innovative Tripolar EEG (tEEG)
This study is testing a new type of EEG technology to help doctors better detect seizures in people with epilepsy, making it easier to pinpoint where in the brain the seizures are happening.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cremedical Corporation NIH-funded |
| Lab location | 1 site (East Greenwich, UNITED STATES) |
| Project ID | NIH-11009476 on NIH RePORTER |
What this research studies
This research focuses on enhancing the detection of seizures in epilepsy patients using a new type of EEG technology called tripolar EEG (tEEG). The innovative tripolar concentric ring electrode sensor aims to improve the accuracy of EEG readings by reducing artifact contamination, which is a common issue that can lead to misdiagnosis. By providing better signal fidelity and spatial resolution, this technology seeks to help clinicians more effectively localize areas of the brain responsible for seizures. The project includes both non-clinical and clinical activities to transition this technology from the lab to real-world clinical use.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with epilepsy who experience frequent seizures and may benefit from improved diagnostic techniques.
Not a fit: Patients who do not have epilepsy or those whose seizures are well-managed with current diagnostic methods may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and better management of epilepsy, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown promise in improving EEG technology for seizure detection, but this specific approach using tripolar EEG is relatively novel.
Where this research is happening
East Greenwich, UNITED STATES
- Cremedical Corporation — East Greenwich, United States (Active)
Researchers
- Principal investigator: Besio, Walter Grant — Cremedical Corporation
- Study coordinator: Besio, Walter Grant
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.